Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
139 tokens/sec
GPT-4o
7 tokens/sec
Gemini 2.5 Pro Pro
46 tokens/sec
o3 Pro
4 tokens/sec
GPT-4.1 Pro
38 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Learning the Covariance of Treatment Effects Across Many Weak Experiments (2402.17637v2)

Published 27 Feb 2024 in stat.ME

Abstract: When primary objectives are insensitive or delayed, experimenters may instead focus on proxy metrics derived from secondary outcomes. For example, technology companies often infer the long-term impacts of product interventions from their effects on short-term user engagement signals. We consider the meta-analysis of many historical experiments to learn the covariance of treatment effects on these outcomes, which can support the construction of such proxies. Even when experiments are plentiful, if treatment effects are weak, the covariance of estimated treatment effects across experiments can be highly biased. We overcome this with techniques inspired by weak instrumental variable analysis. We show that Limited Information Maximum Likelihood (LIML) learns a parameter equivalent to fitting total least squares to a transformation of the scatterplot of treatment effects, and that Jackknife Instrumental Variables Estimation (JIVE) learns another parameter computable from the average of Jackknifed covariance matrices across experiments. We also present a total covariance estimator for the latter estimand under homoskedasticity, which is equivalent to a $k$-class estimator. We show how these parameters can be used to construct unbiased proxy metrics under various structural models. Lastly, we discuss the real-world application of our methods at Netflix.

Definition Search Book Streamline Icon: https://streamlinehq.com
References (15)
  1. The limited information maximum likelihood estimator as an angle. CIRJE No. CIRJE-F-619, CIRJE, Faculty of Economics, University of Tokyo, 2009.
  2. Jackknife instrumental variables estimation. Journal of Applied Econometrics, 14(1):57–67, 1999.
  3. Estimating treatment effects using multiple surrogates: The role of the surrogate score and the surrogate index. arXiv preprint arXiv:1603.09326, 2016.
  4. Combining experimental and observational data to estimate treatment effects on long term outcomes. arXiv preprint arXiv:2006.09676, 2020.
  5. Interpreting findings from mendelian randomization using the mr-egger method. European journal of epidemiology, 32:377–389, 2017.
  6. Semiparametric estimation of long-term treatment effects. Journal of Econometrics, 237(2):105545, 2023.
  7. Interpreting experiments with multiple outcomes. 2020.
  8. Surrogacy marker paradox measures in meta-analytic settings. Biostatistics, 16(2):400–412, 2015.
  9. Estimation with weak instruments: Accuracy of higher-order bias and mse approximations. The Econometrics Journal, 7(1):272–306, 2004.
  10. Focusing on the long-term: It’s good for users and business. In Proceedings of the 21th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, pages 1849–1858, 2015.
  11. Long-term causal inference under persistent confounding via data combination. arXiv preprint arXiv:2202.07234, 2022.
  12. On the role of surrogates in the efficient estimation of treatment effects with limited outcome data. arXiv preprint arXiv:2003.12408, 2020.
  13. Learning causal effects from many randomized experiments using regularized instrumental variables. In Proceedings of the 2018 World Wide Web Conference, pages 699–707, 2018.
  14. Ross L Prentice. Surrogate endpoints in clinical trials: definition and operational criteria. Statistics in medicine, 8(4):431–440, 1989.
  15. Choosing a proxy metric from past experiments. arXiv preprint arXiv:2309.07893, 2023.
Citations (2)

Summary

  • The paper develops innovative estimation methods using LIML and Jackknife to accurately learn covariance matrices from weak treatment effects.
  • It demonstrates that advanced statistical techniques can mitigate bias in noisy, short-term experiments for reliable proxy metrics.
  • Practical validation with Netflix data underscores the approach’s potential to enhance causal inference and guide future research.

Learning the Covariance of Treatment Effects Across Many Weak Experiments

The paper "Learning the Covariance of Treatment Effects Across Many Weak Experiments" addresses a critical challenge in contemporary data-driven decision-making processes, particularly in experimentation contexts prevalent at technology companies like Netflix. The authors focus on constructing reliable proxy metrics for long-term outcomes based on short-term experimental data, leveraging the covariance of treatment effects across numerous experiments. They contribute significantly to the field by developing methods to estimate these covariances, even when individual experiments exhibit low signal-to-noise ratios, drawing inspiration from the literature on weak instrumental variable analysis.

Methodological Contributions

The core contribution lies in the estimation techniques for the covariance matrix of true average treatment effects (ATEs) when ATEs are inherently weak, which poses a significant problem due to bias when using traditional methods. The paper innovatively adapts techniques from weak IV analysis, specifically the Limited Information Maximum Likelihood (LIML) and Jackknife Instrumental Variables Estimation (JIVE). These techniques enable the estimation of covariance matrices and further allow constructing metrics that approximate the effects of interventions on long-term outcomes.

Key methodological insights include:

  1. Jackknife Estimation: The authors propose using a Jackknife approach to construct unbiased estimators for the covariance matrix. This method effectively addresses the bias introduced by small treatment effects in large-scale digital experiments.
  2. LIML and Total Least Squares (TLS): They establish that LIML can accurately estimate parameters equivalent to a symmetric transformation of treatment effect scatterplots. This approach mitigates bias from weak instruments, presenting an alternative to typical OLS regression on estimated ATEs.
  3. Numerical Simulations: Through rigorous simulation studies, the paper demonstrates the effectiveness of these methods relative to naive approaches. Particularly, they underscore the consistency and efficiency of LIML under certain causal structures, while highlighting its limitations in scenarios involving direct effects.

Practical and Theoretical Implications

The paper's implications are manifold. Practically, the authors exhibit the applicability of their methodologies using data from Netflix, where an accurate proxy for long-term user engagement and retention can optimize decision-making. By leveraging these advanced covariate estimation techniques, businesses can potentially infer long-term intervention effects without needing prolonged and expansive data collection efforts.

Theoretically, the work enriches the meta-analytical framework of surrogacy in causal inference, presenting a robust pathway for utilizing historical experiment data. This circumvents the challenges posed by computational complexity and potentially inconsistent estimations due to low treatment effect signal strength.

Future Directions

Future research avenues highlighted by this work involve extending the estimators to accommodate more intricate causal models and heteroskedastic noise environments. Additionally, the development of diagnostic tools to evaluate direct effects in various experimental settings, beyond INSIDE assumptions, remains an open area for further exploration.

In conclusion, the paper makes a substantive addition to data analysis and causal inference literature, providing a robust toolkit for practitioners grappling with the complexities of numerous weak experiments. These advancements promise more precise and unbiased inference of long-term treatment effects using short-term experimental data. The adaptability and operational feasibility of the proposed methods ensure their relevance across diverse experimentation platforms globally.